Page 4 of lupin

Brain implants work by interpreting the brain’s electrical activity. (Image: Freepik)

Addressing the Alarming Rise in Stroke Cases and the Unmet Rehabilitation Needs in India

According to the World Health Organization (WHO), it is the second leading cause of death and the third leading cause…

October 29, 2024 21:54 IST

Lupin share price today, Lupin share news

Lupin to focus on developing inhalers with near-zero global warming potential propellants

In the respiratory category, Lupin’s strategy includes the inhalation portfolio with accelerated development of pipeline products and green propellant development…

October 28, 2024 16:50 IST

Lupin Appoints Claus Jepsen as President, Global Specialty

Claus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.

October 21, 2024 17:43 IST

Lupin launches first generic formulation of Abbie’s drug to treat eye disorder

Pred Forte had estimated annual sales of USD 198 million in the U.S., as per IQVIA MAT August 2024.

October 15, 2024 15:53 IST

Lupin acquires nine brands of Medical Nutritional Institute in South Africa

This acquisition will enable Lupin gain access to MNI’s wide portfolio of nine brands, that are marketed as branded products…

October 4, 2024 15:22 IST

Lupin Launches generic formulation to treat ovarian cancer in United States

Doxorubicin Hydrochloride Liposome Injection (RLD Doxil (Liposomal)) had an estimated annual sales of USD40.9 million in the U.S. (IQVIA MAT…

August 30, 2024 09:34 IST

USFDA gives nod to Lupin’s generic formulation for eye disorder treatment

This product will be manufactured at Lupin’s Pithampur facility in India.

August 28, 2024 12:55 IST

Lupin Q1 Results: Net profit jumps 77% to Rs 801 crore, revenue rises to Rs 5,600 crore

Lupin Q1 Results: In the India business, the company reported that the formulation sales for Q1 FY2025 sales were Rs.…

August 7, 2024 11:34 IST

Lupin completes global Phase 3 trial of its biosimilar candidate to treat eye disorder

The data from this Phase 3 study will be part of Lupin’s application for marketing approval with the U.S. FDA…

August 5, 2024 17:38 IST

USFDA gives nod to Lupin’s generic formulation to treat eye diseases

Prednisolone Acetate Ophthalmic Suspension USP, 1% (RLD Pred Forte) had estimated annual sales of USD 198 million in the U.S.…

August 5, 2024 15:23 IST

USFDA gives tentative nod to Lupin’s generic formulation to treat HIV infection

Emtricitabine and Tenofovir Alafenamide Tablets are indicated to treat or prevent HIV-1 infection in adults and children who weigh at…

July 31, 2024 17:53 IST

Lupin acquires two respiratory segment brands from Sanofi

USFDA gives nod to Lupin’s generic formulation to treat eye condition

Olopatadine Hydrochloride Ophthalmic Solution USP (RLD Pataday) had an estimated annual sale of USD 22 million in the U.S. (IQVIA…

June 27, 2024 17:24 IST

Lupin appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary

Abdel holds a Doctorate in Chemical Engineering and a Master’s degree in Business Administration from the University of Southern Queensland.

June 17, 2024 18:14 IST

Lupin acquires two respiratory segment brands from Sanofi

This acquisition will enhance Lupin’s Respiratory business in Germany, by aiding in the expansion of the newly established franchise, following…

June 5, 2024 12:08 IST

USFDA gives nod to Lupin's generic formulation for heart rhythm disorder treatment

USFDA gives nod to Lupin’s generic formulation for Leukemia treatment

According to the company’s statement, the approval has been granted to market a generic equivalent to the reference listed drug…

May 16, 2024 12:36 IST

USFDA gives nod to Lupin’s generic formulation to treat glaucoma

Travoprost Ophthalmic Solution USP, 0.004% (RLD Travatan Z), had estimated annual sales of USD 77 million in the U.S. (IQVIA…

May 6, 2024 17:28 IST

Use of digital therapeutics for cardiac rehab has gained significant traction in India: Sidharth Srinivasan, CEO, Lupin Digital Health

Digital therapeutics (DTx) is a rapidly evolving field that leverages technology to prevent, treat or manage medical conditions, Srinivasan told…

May 3, 2024 15:14 IST

USFDA inspection of Lupin’s Dabhasa Facility completed; No observations reported

According to the company’s press statement, the inspection was conducted from April 8 to April 12, 2024, and concluded with…

April 12, 2024 15:26 IST

Related News

Your job appointment letter and salary slip are set to change with new labour laws — what to expect

Your job appointment letter and salary slip will change soon — here’s what new labour laws bring

FIIs defy sector gloom to buy this power stock: What’s Driving the 400% Profit Surge?

Not Adani, Not Tata: The one power stock FIIs are aggressively buying now

H-1B visa, H-1B visa ban, H-1B visa program, temporary visa program, foreign worker program

US lawmaker proposes complete ban of H-1B visa program

Maharashtra local body election result 2025 date and time: When and where to check civic poll results

Meta’s $14 billion AI hire Alexandr Wang finds Mark Zuckerberg’s micromanagement ‘suffocating’: Report

Thyroid imbalance and its impact on organs

Life21 min ago

Thyroid imbalance can have serious effects on the eyes, including inflammation, puffiness, and difficulty closing them. In severe cases, it can lead to double vision, bulging eyes, and vision loss. Early detection and treatment are crucial to prevent complications and preserve eye health.

View all shorts